Table 1.
Power calculations for the JIA study
SNP | Locus | Allele frequency | Effect size (OR) | Power of JIA study (%)* |
---|---|---|---|---|
rs10910099†,‡ | MMEL | 0.66 | 0.9 | 53 |
rs11889341§ | STAT4 | 0.22 | 1.12 | 48 |
rs7574865§ | STAT4 | 0.22 | 1.17 | 76 |
rs8179673§ | STAT4 | 0.22 | 1.13 | 55 |
rs10181656§ | STAT4 | 0.22 | 1.13 | 55 |
rs13207033¶ | TNFAIP3 | 0.79 | 0.86 | 67 |
rs6920220‡ | TNFAIP3 | 0.22 | 1.22 | 93 |
rs42041** | CDK6 | 0.24 | 1.15 | 69 |
rs3761847§ | TRAF1 | 0.43 | 1.11 | 55 |
rs10818488§ | TRAF1 | 0.43 | 1.12 | 62 |
rs2900180§ | TRAF1 | 0.35 | 1.17 | 86 |
rs2812378** | CCL21 | 0.34 | 1.12 | 59 |
rs4750316‡ | PRKCQ | 0.80 | 0.85 | 72 |
rs1678542‡ | KIF5A | 0.63 | 0.88 | 69 |
rs4810485** | CD40 | 0.75 | 0.84 | 84 |
Sample size, 1054 JIA cases and 3531 controls.
At α value 0.05, assuming a log-additive model;
SNP in r2=0.95 with the SNP associated with RA in the WTCCC study;
Barton et al (2008)19;
Barton et al (2008)14;
Raychaudhuri et al (2008)20;
Orozco et al (2009) (submitted).
JIA, juvenile idiopathic arthritis; OR, odds ratio; RA, rheumatoid arthritis; SNP, single nucleotide polymorphism.